BioPharma Credit signs $200 million loan agreement with Tarsus Pharmaceuticals
LONDON: BioPharma Credit PLC (LSE: BPCR), a leading debt investment trust specializing in life sciences, has declared a substantial financial deal with Tarsus Pharmaceuticals, Inc. The agreement, facilitated by BioPharma Credit’s wholly-owned subsidiary and BioPharma Credit Investments V (Master) LP,…